pressure limit. Patients in the treatment group also tended to receive more red blood cell transfusion. Avoidance of transfusion, especially when hemoglobin levels exceed 8 g/dL, is known to lower the risk for developing AKI in patients undergoing CPB surgery [4] . Third, patients in the treatment group required less RRT but had higher mortality, suggesting that the higher incidence of RRT in controls might reflect severity of illness rather than occurrence of AKI. Finally, a very recently published large controlled trial in patients undergoing elective valve replacement with CPB could not confirm a renal protective effect of ulinastatin [5] . Also, before promoting a more widespread use of ulinastatin, its effects in a predominantly non-Asian population as well as a standard dosing guideline should be better established.
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